Nicole S. Jones - 04 Aug 2026 Form 4 Insider Report for Cigna Group (CI)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
06 Aug 2026, 16:31:13 UTC
Prior SEC filing
03 Mar 2026
Next SEC filing
20 Aug 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
Tyler Gratton, attorney-in-fact

Key filing fact

Nicole S. Jones filed Form 4 for Cigna Group (CI) on 06 Aug 2026.

Key facts

  • This page summarizes Nicole S. Jones's Form 4 filing for Cigna Group (CI).
  • 5 reported transactions and 2 derivative rows are listed below.
  • Accepted by SEC: 06 Aug 2026, 16:31.

Change

  • Previous filing in this sequence was filed on 03 Mar 2026.
  • Current net transaction value: -$5,369,584.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001492663 Primary reporting owner

Jones Nicole S

Relationship
EVP, Chief Administrative Officer and Chief Human Resources Officer
Address
900 COTTAGE GROVE ROAD, BLOOMFIELD
Signature
Tyler Gratton, attorney-in-fact
Signature date
06 Aug 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

CI transaction

Common Stock, $.01 Par Value

Options Exercise

Transaction value
Shares
+14,045
Change %
+43%
Price
$192.02*
Shares after
46,692
Date
04 Aug 2026
Ownership
Direct
Footnotes
F1
CI transaction

Common Stock, $.01 Par Value

Sale

Transaction value
$5,369,584
Shares
-19,436
Change %
-42%
Price
$276.27
Shares after
27,256
Date
04 Aug 2026
Ownership
Direct
Footnotes
F1
CI transaction

Common Stock, $.01 Par Value

Options Exercise

Transaction value
Shares
+1,301
Change %
+4.8%
Price
$192.02*
Shares after
28,557
Date
05 Aug 2026
Ownership
Direct
Footnotes
F1
CI holding

Common Stock, $.01 Par Value

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
1,451
Date
04 Aug 2026
Ownership
By 401(k)
Footnotes
F2

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

CI transaction Derivative

Employee Stock Option (Right to Buy)

Options Exercise

Transaction value
Shares
-14,045
Change %
-92%
Price
$0.000000*
Shares after
1,301
Date
04 Aug 2026
Ownership
Direct
Underlying class
Common Stock, $.01 Par Value
Underlying amount
14,045
Exercise price
$192.02
Footnotes
F1, F3
CI transaction Derivative

Employee Stock Option (Right to Buy)

Options Exercise

Transaction value
Shares
-1,301
Change %
-100%
Price
$0.000000*
Shares after
0
Date
05 Aug 2026
Ownership
Direct
Underlying class
Common Stock, $.01 Par Value
Underlying amount
1,301
Exercise price
$192.02
Footnotes
F1, F3
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Rule 10b5-1 trading plan

These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.

Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).

Explanation of responses 3 footnotes

Footnote F1

These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 4, 2026.

Footnote F2

Represents shares acquired through ongoing participation in The Cigna Group's 401(k) Plan.

Footnote F3

This option was granted on February 26, 2020. The option vested in three equal annual installments on the first, second and third anniversaries of the grant date.

SEC remarks

EVP, Chief Administrative Officer and Chief Human Resources Officer

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .